Publication date: 9 October 2026 Source: Med, Volume 7, Issue 10 Author(s): Margot A. Cousin, Aditi I. Dagli, Laurence Mignon, Jaimin S. Shah, Mercedes Prudencio, Tania F. Gendron, Angita Jain, Evan Udine, Marka van Blitterswijk, Erik H. Middlebrooks, Megan H. Donahue, Jany E. Dagher, Jens O. Watzlawik, Wolfdieter Springer, Tejal Parekh, Zachary T. McEachin, Leonard Petrucelli, Björn Oskarsson
N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy. // Med. – URL: https://www.sciencedirect.com/science/article/pii/S2666634026002989?dgcid=rss_sd_all
N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy. Med. https://www.sciencedirect.com/science/article/pii/S2666634026002989?dgcid=rss_sd_all
“N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy.” Med.
@article{article58203,
title = {N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy},
journal = {Med},
url = {https://www.sciencedirect.com/science/article/pii/S2666634026002989?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...